Free Trial

Omega Therapeutics (OMGA) SEC Filings & 10K Form

Omega Therapeutics logo
$0.83 -0.18 (-17.85%)
(As of 11/15/2024 ET)

Recent Omega Therapeutics SEC Filings

DateFilerForm TypeView
11/15/2024
5:09 PM
Certel Kaan (Reporting)
Omega Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:10 PM
Omega Therapeutics (Issuer)
Rosiello Robert L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:00 PM
Omega Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
4:01 PM
Omega Therapeutics (Issuer)
Rosiello Robert L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/30/2024
3:01 PM
Omega Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
6:02 AM
Omega Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
6:03 AM
Omega Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/21/2024
3:15 PM
Kender Richard N (Reporting)
Omega Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/31/2024
3:49 PM
Chan Barbara Y (Reporting)
Omega Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/31/2024
3:50 PM
Certel Kaan (Reporting)
Omega Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/31/2024
3:57 PM
Certel Kaan (Reporting)
Omega Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
4:04 PM
Omega Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2024
4:10 PM
Omega Therapeutics (Filer)
Form 8-K/A
05/06/2024
6:04 AM
Omega Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
6:06 AM
Omega Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
6:15 AM
Omega Therapeutics (Filer)
Form DEFA14A
04/29/2024
6:00 AM
Omega Therapeutics (Filer)
Form DEF 14A
04/16/2024
3:20 PM
Omega Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
11:03 AM
Omega Therapeutics (Subject)
Form SC 13G/A
02/09/2024
3:17 PM
HarbourVest Partners L.P. (Filed by)
Omega Therapeutics (Subject)
Form SC 13G/A
02/09/2024
8:28 AM
FMR LLC (Filed by)
Omega Therapeutics (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:OMGA) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners